Literature DB >> 23878311

Osteoarthritis: a progressive disease with changing phenotypes.

Santos Castañeda1, Jorge A Roman-Blas, Raquel Largo, Gabriel Herrero-Beaumont.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23878311     DOI： 10.1093/rheumatology/ket247

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  19 in total

Review 1.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

Authors:  V B Kraus; F J Blanco; M Englund; M A Karsdal; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2015-04-09       Impact factor: 6.576

2.  Characterization of synovial fluid metabolomic phenotypes of cartilage morphological changes associated with osteoarthritis.

Authors:  A K Carlson; R A Rawle; C W Wallace; E G Brooks; E Adams; M C Greenwood; M Olmer; M K Lotz; B Bothner; R K June
Journal:  Osteoarthritis Cartilage       Date:  2019-04-25       Impact factor: 6.576

3.  Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchanged.

Authors:  Gabriel Herrero-Beaumont; Raquel Largo
Journal:  Nat Rev Rheumatol       Date:  2017-08-17       Impact factor: 20.543

4.  Classification of osteoarthritis phenotypes by metabolomics analysis.

Authors:  Weidong Zhang; Sergei Likhodii; Yuhua Zhang; Erfan Aref-Eshghi; Patricia E Harper; Edward Randell; Roger Green; Glynn Martin; Andrew Furey; Guang Sun; Proton Rahman; Guangju Zhai
Journal:  BMJ Open       Date:  2014-11-19       Impact factor: 2.692

5.  Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.

Authors:  Olivier Bruyère; Cyrus Cooper; Nigel Arden; Jaime Branco; Maria Luisa Brandi; Gabriel Herrero-Beaumont; Francis Berenbaum; Elaine Dennison; Jean-Pierre Devogelaer; Marc Hochberg; John Kanis; Andrea Laslop; Tim McAlindon; Susanne Reiter; Pascal Richette; René Rizzoli; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 3.923

6.  Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal Joint.

Authors:  A Migliore; E Bizzi; O De Lucia; A Delle Sedie; S Tropea; M Bentivegna; A Mahmoud; C Foti
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-06-07

7.  Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis.

Authors:  Mingjian Huang; Jingyu Zhao; Yan Huang; Liming Dai; Xiaoling Zhang
Journal:  J Orthop Translat       Date:  2017-08-15       Impact factor: 5.191

8.  A Histopathological Scheme for the Quantitative Scoring of Intervertebral Disc Degeneration and the Therapeutic Utility of Adult Mesenchymal Stem Cells for Intervertebral Disc Regeneration.

Authors:  Cindy C Shu; Margaret M Smith; Susan M Smith; Andrew J Dart; Christopher B Little; James Melrose
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

9.  Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis.

Authors:  Yu-Hsiang Hsu; Ya-Yu Yang; Man-Hsiang Huwang; Yun-Han Weng; I-Ming Jou; Po-Tin Wu; Tain-Yu Lin; Li-Wha Wu; Ming-Shi Chang
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 10.  The Value of Phenotypes in Knee Osteoarthritis Research.

Authors:  Fred R T Nelson
Journal:  Open Orthop J       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.